Philips announces 2 million share buyback to meet dividends and incentive plans

Royal Philips, a global leader in health technology, announced that it will repurchase up to 2 million shares to cover long-term incentive and employee stock purchase plans. At the current share price, the shares amount to approximately EUR 91 million ($110.8 million).

The repurchase is a part of the plan announced on January 29, 2019, during its annual results. It was proposed to increase dividend by 6% to EUR 0.85 per share, with the start of a new EUR 1.5 billion share buyback program.

The repurchases will be executed through one or more individual forward transactions, to be entered into in the course of the second quarter of 2021, under the Market Abuse Regulation and within the limits of the authorization granted by the company’s General Meeting of Shareholders on May 6, 2021, announced the company.

Philips expects to take delivery of the shares in 2023.

Royal Philips Share Buyback

The distribution will be payable in cash or in shares, at the option of the shareholder, against the net income for 2020. The shares will trade ex-dividend at Euronext Amsterdam and the New York Stock Exchange.

The number of share dividend rights will be determined based on the volume-weighted average price of all traded common shares at Euronext Amsterdam on June 2, 3 and 4, 2021.

The ratio and the number of shares to be issued will be announced on June 8, 2021. People could indicate their choice of cash or receiving additional shares by May 12.

Dividend in cash is subject to 15% tax, which will be deducted from the dividend in cash paid to the shareholders at the par value of the shares (which value amounts to EUR 0.20 per share). 

Holders of ordinary shares in the form of K-shares who wish to collect their dividend after June 8, 2021, will receive it in cash.

According to the company, 50.3% of the program has been completed through repurchases. This new announcement will cover the rest.

By using forward transactions, Philips aims to optimize the number of shares to be repurchased under the program to maintain its current liquidity and reduce any further impact of COVID-19 pandemic on its finances.

In related news, Royal Philips announces some innovative digital imaging products at EuroPCR 2021 (May 18-20). During the virtual event, Philips showed three new innovative products integrating digital imaging with software platforms for better cardiac care.

“At Philips we envision personalized, efficient and clinically smart cardiac care that drives optimal outcomes throughout the patient journey,” said Bert van Meurs, Chief Business Leader for Image-Guided Therapy at Philips. “At this year’s virtual EuroPCR we’re showcasing how we bring together devices, systems, software and services that improve cardiac care by strengthening clinical confidence, building efficiency throughout the care pathway and improving the experience for both patients and staff.”

The new Philips Interventional Applications Platform called IntraSight Mobile brings together imaging and physiology applications on a mobile system for coronary and peripheral artery disease therapy. 

It also launched Philips Omniwire Pressure Guide Wire, the world’s first solid-core pressure wire for coronary artery interventions. It will be available in Europe, initially.

Philips also showcased its new Laser System, which offers plug-and-play simplicity for coronary procedures. The system can be used for lead extraction, that is, the removal of pacemaker or defibrillator leads around the heart, a first of its kind. 

Anna Domanska
Anna Domanska is an Industry Leaders Magazine author possessing wide-range of knowledge for Business News. She is an avid reader and writer of Business and CEO Magazines and a rigorous follower of Business Leaders.

Leave a Reply

Your email address will not be published.

Recent Posts

Juul Products Banned – Will The FDA Win The Battle?

Juul Products Banned – Will The FDA Win The Battle?

In a written statement, FDA Commissioner Robert M. Califf stated, “Today’s action is further progress on the FDA’s commitment to ensuring that all e-cigarette and electronic
11 hours ago
The Mark Cuban Cost Plus Drug Company Takes on Big Pharmas

The Mark Cuban Cost Plus Drug Company Takes on Big Pharmas

Commonly used generic drugs are available at a 15% markup, plus a $3 dispensing fee and $5 shipping fee. In an interview with PBS News, Cuban told the host that the Mark Cuban phar
12 hours ago
The Brookfield Global Transition Fund Promises Net Zero Returns

The Brookfield Global Transition Fund Promises Net Zero Returns

According to a written statement issued by the company, they have already deployed $2.5 billion to fund decarbonization technologies in the US, the UK, Germany, and North America.
18 hours ago
Network Configuration Error Causes Cloudflare Outage Across 19 Locations

Network Configuration Error Causes Cloudflare Outage Across 19 Locations

The Cloudflare outage was most problematic for users of Cloudflare’s DNS lookup service. “Customers attempting to reach Cloudflare sites in impacted regions will observe 50
2 days ago
Tesla Employee Lawsuit Alleges Violation of Federal Law Amidst Layoffs

Tesla Employee Lawsuit Alleges Violation of Federal Law Amidst Layoffs

Tesla laying off employees has impacted workers across divisions from human resources to engineering. The plaintiffs are seeking 60 days of compensation and benefits for all those
3 days ago
Nasdaq’s Opening Bell Ushers in a Metaverse Moment for Women

Nasdaq’s Opening Bell Ushers in a Metaverse Moment for Women

Back in 2020, she wrote a feature for Forbes, where she confidently penned that a new era will herald all good things metaverse, she asserted that it “will unleash amazing creati
3 days ago